CSX
51
-2
PSA
51
-4
NOV
58
3
EIX
77
2
AES
39
-4
DG
2
-6
HPE
55
11
DHI
48
3
CINF
47
2
USB
50
2
AZO
46
-3
TGNA
53
2
IVZ
46
3
UA
45
-3
FMC
31
5
EL
20
3
T
50
3
NI
75
2
F
43
-8
VRSK
73
5
CSX
51
-2
PSA
51
-4
NOV
58
3
EIX
77
2
AES
39
-4
DG
2
-6
HPE
55
11
DHI
48
3
CINF
47
2
USB
50
2
AZO
46
-3
TGNA
53
2
IVZ
46
3
UA
45
-3
FMC
31
5
EL
20
3
T
50
3
NI
75
2
F
43
-8
VRSK
73
5
Financhill
Back

Lexicon Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison

Sell
20

LXRX
Lexicon Pharmaceuticals

Last Price:
0.77
Seasonality Move:
23.34%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Sell
20
Lexicon Pharmaceuticals (LXRX) is a Sell

Is Lexicon Pharmaceuticals a Buy, Sell or Hold?

  • The current Lexicon Pharmaceuticals [LXRX] share price is $0.81. The Score for LXRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • LXRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LXRX Stock Price Chart

What is Lexicon Pharmaceuticals's stock price today?

  • The Lexicon Pharmaceuticals share price today is $0.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

LXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 21.81 Sell
Chaikin Money Flow: -2271611 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.05 - 1.89) Sell
Bollinger Bands (100): (1.38 - 2) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 12.88) Sell
Bollinger Bands (100): (10.81 - 14.53) Sell

LXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.02 Sell
20-day SMA: 1.35 Sell
50-day SMA: 1.56 Sell
200-day SMA: 1.87 Sell
8-day EMA: 1 Sell
20-day EMA: 1.25 Sell
50-day EMA: 1.48 Sell
200-day EMA: 1.72 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.14 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Lexicon Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):